Research highlights improved lung cancer biomarker testing in North America, though delays, costs, and limited satisfaction ...

ABBV-706 is an ADC targeting SEZ6 developed by AbbVie. It is linked to a topoisomerase 1 inhibitor (TOP1i) via a ...

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before ...